Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MBX BiosciencesMBX +1.06%14 5-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates MBX with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,120 Biotechnology companies, MBX Biosciences ranks worse than 89285.63% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. MBX Biosciences's current 5-Year Share Buyback Ratio was 0.00%.
MBX's 5-Year Share Buyback Ratio is not ranked *
in the Biotechnology industry.
Industry Median: -10.3 * Ranked among companies with meaningful 5-Year Share Buyback Ratio only.
MBX Biosciences (NAS:MBX) 5-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
MBX Biosciences 5-Year Share Buyback Ratio Related Terms
MBX vs IRON, CLDX, QURE: 5-Year Share Buyback Ratio Comparison
For the Biotechnology subindustry, MBX Biosciences's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MBX Biosciences 5-Year Share Buyback Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MBX Biosciences's 5-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where MBX Biosciences's 5-Year Share Buyback Ratio falls into.
MBX Biosciences 5-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 5-Year Share Buyback Ratio of 0.00 mean?
MBX Biosciences (MBX) has a 5-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for MBX Biosciences and its competitors. According to the industry distribution chart, MBX Biosciences ranks #999999 out of 1120 companies in the Biotechnology industry.
Is MBX Biosciences' 5-Year Share Buyback Ratio too high?
MBX Biosciences' current 5-Year Share Buyback Ratio is 0.00. Based on the distribution chart, MBX Biosciences ranks #999999 out of 1120 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MBX Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does MBX Biosciences' 5-Year Share Buyback Ratio compare to IRON and CLDX?
According to the Biotechnology industry distribution chart, MBX Biosciences ranks #999999 out of 1120 companies for 5-Year Share Buyback Ratio. This places MBX Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Share Buyback Ratio for a Biotechnology company?
A good 5-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 5-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Share Buyback Ratio mean?
A high 5-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. View historical data for MBX Biosciences and its competitors. MBX Biosciences's current 5-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MBX Biosciences stock overvalued right now?
MBX Biosciences (MBX) has a current 5-Year Share Buyback Ratio of 0.00. The current 5-Year Share Buyback Ratio is 0.00. MBX Biosciences' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Share Buyback Ratio calculated?
5-Year Share Buyback Ratio is calculated from a company's financial statements. For MBX Biosciences (MBX), the current 5-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
14GF Score
Get the complete analysis for MBX
5-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBX has been successfully added to your 
